Enabling Family Physicians to Reduce Vaccine Hesitancy and Increase Covid-19 Vaccine Uptake
Condition(s):Covid19; COVID-19 VaccineLast Updated:March 1, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Covid19; COVID-19 VaccineLast Updated:March 1, 2023Recruiting
Condition(s):Coronavirus Disease (COVID-19)Last Updated:May 19, 2023Completed
Condition(s):Coronavirus Disease (COVID-19)Last Updated:July 28, 2022Withdrawn
Condition(s):COVID-19 Vaccine Adverse ReactionLast Updated:May 23, 2023Completed
Condition(s):Adenovirus Type-5 Vectored COVID-19 VaccineLast Updated:March 31, 2022Completed
Condition(s):Vaccine Adverse ReactionLast Updated:June 29, 2022Recruiting
Condition(s):Immunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential ImmunizationLast Updated:May 13, 2022Recruiting
Condition(s):Vaccine Adverse ReactionLast Updated:November 14, 2022Active, not recruiting
Condition(s):COVID-19Last Updated:January 12, 2023Not yet recruiting
Condition(s):Covid19Last Updated:March 26, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.